Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)-Reference-Cited by-同舟云学术

Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)

Published:2018-07-17 Issue: Volume: Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Jiang Nan¹,Lin Jing‑Jing¹,Wang Jun²,Zhang Bei‑Ning¹,Li Ao¹,Chen Zheng‑Yang¹,Guo Song¹,Li Bin‑Bin¹,Duan Yu‑Zhong¹,Yan Ru‑Yi³,Yan Hong‑Feng¹,Fu Xiao‑Yan¹,Zhou Jin‑Lian⁴,Yang He‑Ming¹,Cui Yan¹

Affiliation:

1. Department of General Surgery, 306 Hospital of PLA, Beijing 100101, P.R. China

2. Department of Hepatology, 302 Teaching Hospital of Peking University Health Science Center, Beijing 100101, P.R. China

3. Department of General Surgery, PLA 306 Clinical Hospital of Anhui Medical University, Beijing 230000, P.R. China

4. Department of Pathology, 306 Hospital of PLA, Beijing 100101, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Strategies Using Sagacious Targeting for Site-Specific Drug Delivery in Breast Cancer Treatment: Clinical Potential and Applications;Critical Reviews™ in Therapeutic Drug Carrier Systems;2024

2. Neratinib for HER2-positive breast cancer with an overlooked option;Molecular Medicine;2023-10-06

3. HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 Induction;International Journal of Molecular Sciences;2023-03-25

4. Neoadjuvant Treatment with HER2-Targeted Therapies in HER2-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis;Cancers;2022-01-21

5. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents;Anti-Cancer Agents in Medicinal Chemistry;2021-12-09